diatrizoate meglumine

drug_tag_22628
Back
No image

Description

Approved for medical use in 1954, Diatrizoate Meglumine is a radiocontrast agent used to enhance the visibility of internal structures (i.e. veins, spleen, joints, urinary system…etc) during X-rays or similar tests. Remember to tell your doctor if you’re using any drug at all, because Diatrizoate Meglumine may interact with other drugs or health issues. Besides, this medicine may also affect certain lab tests, which is why it is important that you tell your healthcare provider that you take Diatrizoate Meglumine. Bear in mind that using this medicine during pregnancy or during breastfeeding is not recommended without first consulting a doctor. According to drugs.com, Diatrizoate Meglumine is typically is “given through a catheter into the bladder”. When it comes to its side effects, the medicine in question can cause seizures, bladder irritation, and signs of an allergic reaction such as itching, hives, and trouble breathing. You should, of course, tell your doctor if you experience any of these side effects.
Full size image
0
Subcategories
0
Active
0
Languages
Control Plane

Visual Identity

Source: generated
Icon fas fa-box
Gradient linear-gradient(135deg, #64748b, #475569)
Icon Source generated

Control Plane

No control plane mapping. This entity is not linked to a capability group.

All Languages (0)

Both name + description
Only one
Not translated
Double-click name or description to edit
Language Status Name Translation Description Translation AI Checked Translator Last Updated History

Translation History

Loading history...

Configuration

No configuration attributes set.

Move: diatrizoate meglumine

(root — no parent)